Cargando…
Genetic Perturbation of Pyruvate Dehydrogenase Kinase 1 Modulates Growth, Angiogenesis and Metabolic Pathways in Ovarian Cancer Xenografts
Pyruvate dehydrogenase kinase 1 (PDK1) blockade triggers are well characterized in vitro metabolic alterations in cancer cells, including reduced glycolysis and increased glucose oxidation. Here, by gene expression profiling and digital pathology-mediated quantification of in situ markers in tumors,...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915933/ https://www.ncbi.nlm.nih.gov/pubmed/33562444 http://dx.doi.org/10.3390/cells10020325 |
_version_ | 1783657362658164736 |
---|---|
author | Venturoli, Carolina Piga, Ilaria Curtarello, Matteo Verza, Martina Esposito, Giovanni Venuto, Santina Navaglia, Filippo Grassi, Angela Indraccolo, Stefano |
author_facet | Venturoli, Carolina Piga, Ilaria Curtarello, Matteo Verza, Martina Esposito, Giovanni Venuto, Santina Navaglia, Filippo Grassi, Angela Indraccolo, Stefano |
author_sort | Venturoli, Carolina |
collection | PubMed |
description | Pyruvate dehydrogenase kinase 1 (PDK1) blockade triggers are well characterized in vitro metabolic alterations in cancer cells, including reduced glycolysis and increased glucose oxidation. Here, by gene expression profiling and digital pathology-mediated quantification of in situ markers in tumors, we investigated effects of PDK1 silencing on growth, angiogenesis and metabolic features of tumor xenografts formed by highly glycolytic OC316 and OVCAR3 ovarian cancer cells. Notably, at variance with the moderate antiproliferative effects observed in vitro, we found a dramatic negative impact of PDK1 silencing on tumor growth. These findings were associated with reduced angiogenesis and increased necrosis in the OC316 and OVCAR3 tumor models, respectively. Analysis of viable tumor areas uncovered increased proliferation as well as increased apoptosis in PDK1-silenced OVCAR3 tumors. Moreover, RNA profiling disclosed increased glucose catabolic pathways—comprising both oxidative phosphorylation and glycolysis—in PDK1-silenced OVCAR3 tumors, in line with the high mitotic activity detected in the viable rim of these tumors. Altogether, our findings add new evidence in support of a link between tumor metabolism and angiogenesis and remark on the importance of investigating net effects of modulations of metabolic pathways in the context of the tumor microenvironment. |
format | Online Article Text |
id | pubmed-7915933 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79159332021-03-01 Genetic Perturbation of Pyruvate Dehydrogenase Kinase 1 Modulates Growth, Angiogenesis and Metabolic Pathways in Ovarian Cancer Xenografts Venturoli, Carolina Piga, Ilaria Curtarello, Matteo Verza, Martina Esposito, Giovanni Venuto, Santina Navaglia, Filippo Grassi, Angela Indraccolo, Stefano Cells Article Pyruvate dehydrogenase kinase 1 (PDK1) blockade triggers are well characterized in vitro metabolic alterations in cancer cells, including reduced glycolysis and increased glucose oxidation. Here, by gene expression profiling and digital pathology-mediated quantification of in situ markers in tumors, we investigated effects of PDK1 silencing on growth, angiogenesis and metabolic features of tumor xenografts formed by highly glycolytic OC316 and OVCAR3 ovarian cancer cells. Notably, at variance with the moderate antiproliferative effects observed in vitro, we found a dramatic negative impact of PDK1 silencing on tumor growth. These findings were associated with reduced angiogenesis and increased necrosis in the OC316 and OVCAR3 tumor models, respectively. Analysis of viable tumor areas uncovered increased proliferation as well as increased apoptosis in PDK1-silenced OVCAR3 tumors. Moreover, RNA profiling disclosed increased glucose catabolic pathways—comprising both oxidative phosphorylation and glycolysis—in PDK1-silenced OVCAR3 tumors, in line with the high mitotic activity detected in the viable rim of these tumors. Altogether, our findings add new evidence in support of a link between tumor metabolism and angiogenesis and remark on the importance of investigating net effects of modulations of metabolic pathways in the context of the tumor microenvironment. MDPI 2021-02-05 /pmc/articles/PMC7915933/ /pubmed/33562444 http://dx.doi.org/10.3390/cells10020325 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Venturoli, Carolina Piga, Ilaria Curtarello, Matteo Verza, Martina Esposito, Giovanni Venuto, Santina Navaglia, Filippo Grassi, Angela Indraccolo, Stefano Genetic Perturbation of Pyruvate Dehydrogenase Kinase 1 Modulates Growth, Angiogenesis and Metabolic Pathways in Ovarian Cancer Xenografts |
title | Genetic Perturbation of Pyruvate Dehydrogenase Kinase 1 Modulates Growth, Angiogenesis and Metabolic Pathways in Ovarian Cancer Xenografts |
title_full | Genetic Perturbation of Pyruvate Dehydrogenase Kinase 1 Modulates Growth, Angiogenesis and Metabolic Pathways in Ovarian Cancer Xenografts |
title_fullStr | Genetic Perturbation of Pyruvate Dehydrogenase Kinase 1 Modulates Growth, Angiogenesis and Metabolic Pathways in Ovarian Cancer Xenografts |
title_full_unstemmed | Genetic Perturbation of Pyruvate Dehydrogenase Kinase 1 Modulates Growth, Angiogenesis and Metabolic Pathways in Ovarian Cancer Xenografts |
title_short | Genetic Perturbation of Pyruvate Dehydrogenase Kinase 1 Modulates Growth, Angiogenesis and Metabolic Pathways in Ovarian Cancer Xenografts |
title_sort | genetic perturbation of pyruvate dehydrogenase kinase 1 modulates growth, angiogenesis and metabolic pathways in ovarian cancer xenografts |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915933/ https://www.ncbi.nlm.nih.gov/pubmed/33562444 http://dx.doi.org/10.3390/cells10020325 |
work_keys_str_mv | AT venturolicarolina geneticperturbationofpyruvatedehydrogenasekinase1modulatesgrowthangiogenesisandmetabolicpathwaysinovariancancerxenografts AT pigailaria geneticperturbationofpyruvatedehydrogenasekinase1modulatesgrowthangiogenesisandmetabolicpathwaysinovariancancerxenografts AT curtarellomatteo geneticperturbationofpyruvatedehydrogenasekinase1modulatesgrowthangiogenesisandmetabolicpathwaysinovariancancerxenografts AT verzamartina geneticperturbationofpyruvatedehydrogenasekinase1modulatesgrowthangiogenesisandmetabolicpathwaysinovariancancerxenografts AT espositogiovanni geneticperturbationofpyruvatedehydrogenasekinase1modulatesgrowthangiogenesisandmetabolicpathwaysinovariancancerxenografts AT venutosantina geneticperturbationofpyruvatedehydrogenasekinase1modulatesgrowthangiogenesisandmetabolicpathwaysinovariancancerxenografts AT navagliafilippo geneticperturbationofpyruvatedehydrogenasekinase1modulatesgrowthangiogenesisandmetabolicpathwaysinovariancancerxenografts AT grassiangela geneticperturbationofpyruvatedehydrogenasekinase1modulatesgrowthangiogenesisandmetabolicpathwaysinovariancancerxenografts AT indraccolostefano geneticperturbationofpyruvatedehydrogenasekinase1modulatesgrowthangiogenesisandmetabolicpathwaysinovariancancerxenografts |